Generation Bio to Present at William Blair Biotech Focus Conference
Get Alerts GBIO Hot Sheet
Join SI Premium – FREE
CAMBRIDGE, Mass., July 08, 2021 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), an innovative genetic medicines company creating a new class of non-viral gene therapy, announced today that Geoff McDonough, M.D., president and chief executive officer, will present at the William Blair Biotech Focus Conference 2021 on Thursday, July 15, at 9:00 a.m. ET.
A live webcast of the presentation will be available on the investor section of the company’s website at investors.generationbio.com. A replay will be available there for 30 days following the event.
About Generation Bio
Generation Bio is an innovative genetic medicines company focused on creating a new class of non-viral gene therapy to provide durable, redosable treatments for people living with rare and prevalent diseases. The company’s non-viral platform incorporates a proprietary, high-capacity DNA construct called closed-ended DNA, or ceDNA; a cell-targeted lipid nanoparticle delivery system, or ctLNP; and an established, scalable capsid-free manufacturing process. The platform is designed to enable multi-year durability from a single dose of ceDNA and to allow titration and redosing if needed. The ctLNP is designed to deliver large genetic payloads, including multiple genes, to specific tissues to address a wide range of indications. The company’s efficient, scalable manufacturing process supports Generation Bio’s mission to extend the reach of gene therapy to more people, living with more diseases, in more places around the world.
For more information, please visit www.generationbio.com.
Contact:
Investors
Maren Killackey
Generation Bio
[email protected]
541-646-2420
Media
Alicia Webb
Generation Bio
[email protected]
847-254-4275
Stephanie Simon
Ten Bridge Communications
[email protected]
617-581-9333
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- United Fire Group, Inc. Announces Its 2024 First Quarter Earnings Call
- ROSEN, THE FIRST FILING FIRM, Encourages SSR Mining Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – SSRM
- ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages QuidelOrtho Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – QDEL
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesRelated Entities
William BlairSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!